Novel Tools to Improve Patient Selection and Monitoring on Active Surveillance for Low-risk Prostate Cancer: A Systematic Review
Active surveillance (AS) is an alternative to initial radical treatment of low-risk prostate cancer (PCa). Current criteria for selection and follow-up incorrectly exclude some patients eligible for AS and misclassify some who actually harbour significant disease. Better prediction of cancer behavio...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
van den Bergh, Roderick C.N. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
9 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise - Feng, Jing ELSEVIER, 2018, official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:65 ; year:2014 ; number:6 ; pages:1023-1031 ; extent:9 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.eururo.2014.01.027 |
|---|
| Katalog-ID: |
ELV017486238 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV017486238 | ||
| 003 | DE-627 | ||
| 005 | 20230623135038.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.eururo.2014.01.027 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014010000014.pica |
| 035 | |a (DE-627)ELV017486238 | ||
| 035 | |a (ELSEVIER)S0302-2838(14)00096-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 500 |q VZ |
| 084 | |a 33.25 |2 bkl | ||
| 084 | |a 31.00 |2 bkl | ||
| 100 | 1 | |a van den Bergh, Roderick C.N. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Novel Tools to Improve Patient Selection and Monitoring on Active Surveillance for Low-risk Prostate Cancer: A Systematic Review |
| 264 | 1 | |c 2014 | |
| 300 | |a 9 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Active surveillance (AS) is an alternative to initial radical treatment of low-risk prostate cancer (PCa). Current criteria for selection and follow-up incorrectly exclude some patients eligible for AS and misclassify some who actually harbour significant disease. Better prediction of cancer behaviour at diagnosis would allow less strict monitoring and may improve acceptance of AS. | ||
| 650 | 7 | |a Active surveillance |2 Elsevier | |
| 650 | 7 | |a Histopathology |2 Elsevier | |
| 650 | 7 | |a Urinary |2 Elsevier | |
| 650 | 7 | |a MRI |2 Elsevier | |
| 650 | 7 | |a Markers |2 Elsevier | |
| 650 | 7 | |a Prostate cancer |2 Elsevier | |
| 650 | 7 | |a Expectant management |2 Elsevier | |
| 650 | 7 | |a PSA |2 Elsevier | |
| 700 | 1 | |a Ahmed, Hashim U. |4 oth | |
| 700 | 1 | |a Bangma, Chris H. |4 oth | |
| 700 | 1 | |a Cooperberg, Matthew R. |4 oth | |
| 700 | 1 | |a Villers, Arnauld |4 oth | |
| 700 | 1 | |a Parker, Christopher C. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Feng, Jing ELSEVIER |t Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise |d 2018 |d official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology |g Amsterdam [u.a.] |w (DE-627)ELV000464341 |
| 773 | 1 | 8 | |g volume:65 |g year:2014 |g number:6 |g pages:1023-1031 |g extent:9 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.eururo.2014.01.027 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OPC-MAT | ||
| 936 | b | k | |a 33.25 |j Thermodynamik |j statistische Physik |q VZ |
| 936 | b | k | |a 31.00 |j Mathematik: Allgemeines |q VZ |
| 951 | |a AR | ||
| 952 | |d 65 |j 2014 |e 6 |h 1023-1031 |g 9 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
d b r c v dbrc dbrcv |
|---|---|
| matchkey_str |
vandenberghroderickcnahmedhashimubangmac:2014----:oetosomrvpteteetoadoioigncieuvilneolwikr |
| hierarchy_sort_str |
2014 |
| bklnumber |
33.25 31.00 |
| publishDate |
2014 |
| allfields |
10.1016/j.eururo.2014.01.027 doi GBVA2014010000014.pica (DE-627)ELV017486238 (ELSEVIER)S0302-2838(14)00096-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 500 VZ 33.25 bkl 31.00 bkl van den Bergh, Roderick C.N. verfasserin aut Novel Tools to Improve Patient Selection and Monitoring on Active Surveillance for Low-risk Prostate Cancer: A Systematic Review 2014 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Active surveillance (AS) is an alternative to initial radical treatment of low-risk prostate cancer (PCa). Current criteria for selection and follow-up incorrectly exclude some patients eligible for AS and misclassify some who actually harbour significant disease. Better prediction of cancer behaviour at diagnosis would allow less strict monitoring and may improve acceptance of AS. Active surveillance Elsevier Histopathology Elsevier Urinary Elsevier MRI Elsevier Markers Elsevier Prostate cancer Elsevier Expectant management Elsevier PSA Elsevier Ahmed, Hashim U. oth Bangma, Chris H. oth Cooperberg, Matthew R. oth Villers, Arnauld oth Parker, Christopher C. oth Enthalten in Elsevier Science Feng, Jing ELSEVIER Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise 2018 official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology Amsterdam [u.a.] (DE-627)ELV000464341 volume:65 year:2014 number:6 pages:1023-1031 extent:9 https://doi.org/10.1016/j.eururo.2014.01.027 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 33.25 Thermodynamik statistische Physik VZ 31.00 Mathematik: Allgemeines VZ AR 65 2014 6 1023-1031 9 045F 610 |
| spelling |
10.1016/j.eururo.2014.01.027 doi GBVA2014010000014.pica (DE-627)ELV017486238 (ELSEVIER)S0302-2838(14)00096-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 500 VZ 33.25 bkl 31.00 bkl van den Bergh, Roderick C.N. verfasserin aut Novel Tools to Improve Patient Selection and Monitoring on Active Surveillance for Low-risk Prostate Cancer: A Systematic Review 2014 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Active surveillance (AS) is an alternative to initial radical treatment of low-risk prostate cancer (PCa). Current criteria for selection and follow-up incorrectly exclude some patients eligible for AS and misclassify some who actually harbour significant disease. Better prediction of cancer behaviour at diagnosis would allow less strict monitoring and may improve acceptance of AS. Active surveillance Elsevier Histopathology Elsevier Urinary Elsevier MRI Elsevier Markers Elsevier Prostate cancer Elsevier Expectant management Elsevier PSA Elsevier Ahmed, Hashim U. oth Bangma, Chris H. oth Cooperberg, Matthew R. oth Villers, Arnauld oth Parker, Christopher C. oth Enthalten in Elsevier Science Feng, Jing ELSEVIER Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise 2018 official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology Amsterdam [u.a.] (DE-627)ELV000464341 volume:65 year:2014 number:6 pages:1023-1031 extent:9 https://doi.org/10.1016/j.eururo.2014.01.027 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 33.25 Thermodynamik statistische Physik VZ 31.00 Mathematik: Allgemeines VZ AR 65 2014 6 1023-1031 9 045F 610 |
| allfields_unstemmed |
10.1016/j.eururo.2014.01.027 doi GBVA2014010000014.pica (DE-627)ELV017486238 (ELSEVIER)S0302-2838(14)00096-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 500 VZ 33.25 bkl 31.00 bkl van den Bergh, Roderick C.N. verfasserin aut Novel Tools to Improve Patient Selection and Monitoring on Active Surveillance for Low-risk Prostate Cancer: A Systematic Review 2014 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Active surveillance (AS) is an alternative to initial radical treatment of low-risk prostate cancer (PCa). Current criteria for selection and follow-up incorrectly exclude some patients eligible for AS and misclassify some who actually harbour significant disease. Better prediction of cancer behaviour at diagnosis would allow less strict monitoring and may improve acceptance of AS. Active surveillance Elsevier Histopathology Elsevier Urinary Elsevier MRI Elsevier Markers Elsevier Prostate cancer Elsevier Expectant management Elsevier PSA Elsevier Ahmed, Hashim U. oth Bangma, Chris H. oth Cooperberg, Matthew R. oth Villers, Arnauld oth Parker, Christopher C. oth Enthalten in Elsevier Science Feng, Jing ELSEVIER Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise 2018 official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology Amsterdam [u.a.] (DE-627)ELV000464341 volume:65 year:2014 number:6 pages:1023-1031 extent:9 https://doi.org/10.1016/j.eururo.2014.01.027 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 33.25 Thermodynamik statistische Physik VZ 31.00 Mathematik: Allgemeines VZ AR 65 2014 6 1023-1031 9 045F 610 |
| allfieldsGer |
10.1016/j.eururo.2014.01.027 doi GBVA2014010000014.pica (DE-627)ELV017486238 (ELSEVIER)S0302-2838(14)00096-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 500 VZ 33.25 bkl 31.00 bkl van den Bergh, Roderick C.N. verfasserin aut Novel Tools to Improve Patient Selection and Monitoring on Active Surveillance for Low-risk Prostate Cancer: A Systematic Review 2014 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Active surveillance (AS) is an alternative to initial radical treatment of low-risk prostate cancer (PCa). Current criteria for selection and follow-up incorrectly exclude some patients eligible for AS and misclassify some who actually harbour significant disease. Better prediction of cancer behaviour at diagnosis would allow less strict monitoring and may improve acceptance of AS. Active surveillance Elsevier Histopathology Elsevier Urinary Elsevier MRI Elsevier Markers Elsevier Prostate cancer Elsevier Expectant management Elsevier PSA Elsevier Ahmed, Hashim U. oth Bangma, Chris H. oth Cooperberg, Matthew R. oth Villers, Arnauld oth Parker, Christopher C. oth Enthalten in Elsevier Science Feng, Jing ELSEVIER Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise 2018 official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology Amsterdam [u.a.] (DE-627)ELV000464341 volume:65 year:2014 number:6 pages:1023-1031 extent:9 https://doi.org/10.1016/j.eururo.2014.01.027 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 33.25 Thermodynamik statistische Physik VZ 31.00 Mathematik: Allgemeines VZ AR 65 2014 6 1023-1031 9 045F 610 |
| allfieldsSound |
10.1016/j.eururo.2014.01.027 doi GBVA2014010000014.pica (DE-627)ELV017486238 (ELSEVIER)S0302-2838(14)00096-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 500 VZ 33.25 bkl 31.00 bkl van den Bergh, Roderick C.N. verfasserin aut Novel Tools to Improve Patient Selection and Monitoring on Active Surveillance for Low-risk Prostate Cancer: A Systematic Review 2014 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Active surveillance (AS) is an alternative to initial radical treatment of low-risk prostate cancer (PCa). Current criteria for selection and follow-up incorrectly exclude some patients eligible for AS and misclassify some who actually harbour significant disease. Better prediction of cancer behaviour at diagnosis would allow less strict monitoring and may improve acceptance of AS. Active surveillance Elsevier Histopathology Elsevier Urinary Elsevier MRI Elsevier Markers Elsevier Prostate cancer Elsevier Expectant management Elsevier PSA Elsevier Ahmed, Hashim U. oth Bangma, Chris H. oth Cooperberg, Matthew R. oth Villers, Arnauld oth Parker, Christopher C. oth Enthalten in Elsevier Science Feng, Jing ELSEVIER Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise 2018 official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology Amsterdam [u.a.] (DE-627)ELV000464341 volume:65 year:2014 number:6 pages:1023-1031 extent:9 https://doi.org/10.1016/j.eururo.2014.01.027 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 33.25 Thermodynamik statistische Physik VZ 31.00 Mathematik: Allgemeines VZ AR 65 2014 6 1023-1031 9 045F 610 |
| language |
English |
| source |
Enthalten in Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise Amsterdam [u.a.] volume:65 year:2014 number:6 pages:1023-1031 extent:9 |
| sourceStr |
Enthalten in Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise Amsterdam [u.a.] volume:65 year:2014 number:6 pages:1023-1031 extent:9 |
| format_phy_str_mv |
Article |
| bklname |
Thermodynamik statistische Physik Mathematik: Allgemeines |
| institution |
findex.gbv.de |
| topic_facet |
Active surveillance Histopathology Urinary MRI Markers Prostate cancer Expectant management PSA |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise |
| authorswithroles_txt_mv |
van den Bergh, Roderick C.N. @@aut@@ Ahmed, Hashim U. @@oth@@ Bangma, Chris H. @@oth@@ Cooperberg, Matthew R. @@oth@@ Villers, Arnauld @@oth@@ Parker, Christopher C. @@oth@@ |
| publishDateDaySort_date |
2014-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000464341 |
| dewey-sort |
3610 |
| id |
ELV017486238 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV017486238</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623135038.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.eururo.2014.01.027</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014010000014.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV017486238</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0302-2838(14)00096-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">500</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.25</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">31.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">van den Bergh, Roderick C.N.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Novel Tools to Improve Patient Selection and Monitoring on Active Surveillance for Low-risk Prostate Cancer: A Systematic Review</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Active surveillance (AS) is an alternative to initial radical treatment of low-risk prostate cancer (PCa). Current criteria for selection and follow-up incorrectly exclude some patients eligible for AS and misclassify some who actually harbour significant disease. Better prediction of cancer behaviour at diagnosis would allow less strict monitoring and may improve acceptance of AS.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Active surveillance</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Histopathology</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Urinary</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MRI</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Markers</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Prostate cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Expectant management</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PSA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ahmed, Hashim U.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bangma, Chris H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cooperberg, Matthew R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Villers, Arnauld</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Parker, Christopher C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Feng, Jing ELSEVIER</subfield><subfield code="t">Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise</subfield><subfield code="d">2018</subfield><subfield code="d">official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000464341</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:65</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:1023-1031</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.eururo.2014.01.027</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-MAT</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.25</subfield><subfield code="j">Thermodynamik</subfield><subfield code="j">statistische Physik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">31.00</subfield><subfield code="j">Mathematik: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">65</subfield><subfield code="j">2014</subfield><subfield code="e">6</subfield><subfield code="h">1023-1031</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
van den Bergh, Roderick C.N. |
| spellingShingle |
van den Bergh, Roderick C.N. ddc 610 ddc 500 bkl 33.25 bkl 31.00 Elsevier Active surveillance Elsevier Histopathology Elsevier Urinary Elsevier MRI Elsevier Markers Elsevier Prostate cancer Elsevier Expectant management Elsevier PSA Novel Tools to Improve Patient Selection and Monitoring on Active Surveillance for Low-risk Prostate Cancer: A Systematic Review |
| authorStr |
van den Bergh, Roderick C.N. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000464341 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 500 - Natural sciences & mathematics |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 500 VZ 33.25 bkl 31.00 bkl Novel Tools to Improve Patient Selection and Monitoring on Active Surveillance for Low-risk Prostate Cancer: A Systematic Review Active surveillance Elsevier Histopathology Elsevier Urinary Elsevier MRI Elsevier Markers Elsevier Prostate cancer Elsevier Expectant management Elsevier PSA Elsevier |
| topic |
ddc 610 ddc 500 bkl 33.25 bkl 31.00 Elsevier Active surveillance Elsevier Histopathology Elsevier Urinary Elsevier MRI Elsevier Markers Elsevier Prostate cancer Elsevier Expectant management Elsevier PSA |
| topic_unstemmed |
ddc 610 ddc 500 bkl 33.25 bkl 31.00 Elsevier Active surveillance Elsevier Histopathology Elsevier Urinary Elsevier MRI Elsevier Markers Elsevier Prostate cancer Elsevier Expectant management Elsevier PSA |
| topic_browse |
ddc 610 ddc 500 bkl 33.25 bkl 31.00 Elsevier Active surveillance Elsevier Histopathology Elsevier Urinary Elsevier MRI Elsevier Markers Elsevier Prostate cancer Elsevier Expectant management Elsevier PSA |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
h u a hu hua c h b ch chb m r c mr mrc a v av c c p cc ccp |
| hierarchy_parent_title |
Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise |
| hierarchy_parent_id |
ELV000464341 |
| dewey-tens |
610 - Medicine & health 500 - Science |
| hierarchy_top_title |
Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000464341 |
| title |
Novel Tools to Improve Patient Selection and Monitoring on Active Surveillance for Low-risk Prostate Cancer: A Systematic Review |
| ctrlnum |
(DE-627)ELV017486238 (ELSEVIER)S0302-2838(14)00096-7 |
| title_full |
Novel Tools to Improve Patient Selection and Monitoring on Active Surveillance for Low-risk Prostate Cancer: A Systematic Review |
| author_sort |
van den Bergh, Roderick C.N. |
| journal |
Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise |
| journalStr |
Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
1023 |
| author_browse |
van den Bergh, Roderick C.N. |
| container_volume |
65 |
| physical |
9 |
| class |
610 610 DE-600 500 VZ 33.25 bkl 31.00 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
van den Bergh, Roderick C.N. |
| doi_str_mv |
10.1016/j.eururo.2014.01.027 |
| dewey-full |
610 500 |
| title_sort |
novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: a systematic review |
| title_auth |
Novel Tools to Improve Patient Selection and Monitoring on Active Surveillance for Low-risk Prostate Cancer: A Systematic Review |
| abstract |
Active surveillance (AS) is an alternative to initial radical treatment of low-risk prostate cancer (PCa). Current criteria for selection and follow-up incorrectly exclude some patients eligible for AS and misclassify some who actually harbour significant disease. Better prediction of cancer behaviour at diagnosis would allow less strict monitoring and may improve acceptance of AS. |
| abstractGer |
Active surveillance (AS) is an alternative to initial radical treatment of low-risk prostate cancer (PCa). Current criteria for selection and follow-up incorrectly exclude some patients eligible for AS and misclassify some who actually harbour significant disease. Better prediction of cancer behaviour at diagnosis would allow less strict monitoring and may improve acceptance of AS. |
| abstract_unstemmed |
Active surveillance (AS) is an alternative to initial radical treatment of low-risk prostate cancer (PCa). Current criteria for selection and follow-up incorrectly exclude some patients eligible for AS and misclassify some who actually harbour significant disease. Better prediction of cancer behaviour at diagnosis would allow less strict monitoring and may improve acceptance of AS. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT |
| container_issue |
6 |
| title_short |
Novel Tools to Improve Patient Selection and Monitoring on Active Surveillance for Low-risk Prostate Cancer: A Systematic Review |
| url |
https://doi.org/10.1016/j.eururo.2014.01.027 |
| remote_bool |
true |
| author2 |
Ahmed, Hashim U. Bangma, Chris H. Cooperberg, Matthew R. Villers, Arnauld Parker, Christopher C. |
| author2Str |
Ahmed, Hashim U. Bangma, Chris H. Cooperberg, Matthew R. Villers, Arnauld Parker, Christopher C. |
| ppnlink |
ELV000464341 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth |
| doi_str |
10.1016/j.eururo.2014.01.027 |
| up_date |
2024-07-06T22:06:49.640Z |
| _version_ |
1803869077783969792 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV017486238</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623135038.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.eururo.2014.01.027</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014010000014.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV017486238</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0302-2838(14)00096-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">500</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.25</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">31.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">van den Bergh, Roderick C.N.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Novel Tools to Improve Patient Selection and Monitoring on Active Surveillance for Low-risk Prostate Cancer: A Systematic Review</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Active surveillance (AS) is an alternative to initial radical treatment of low-risk prostate cancer (PCa). Current criteria for selection and follow-up incorrectly exclude some patients eligible for AS and misclassify some who actually harbour significant disease. Better prediction of cancer behaviour at diagnosis would allow less strict monitoring and may improve acceptance of AS.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Active surveillance</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Histopathology</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Urinary</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MRI</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Markers</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Prostate cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Expectant management</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PSA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ahmed, Hashim U.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bangma, Chris H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cooperberg, Matthew R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Villers, Arnauld</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Parker, Christopher C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Feng, Jing ELSEVIER</subfield><subfield code="t">Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise</subfield><subfield code="d">2018</subfield><subfield code="d">official organ of the European Association of Urology, the European Organization for Research and Treatment of Cancer - Genito-Urinary Group, the European Society for Urological Oncology and Endocrinology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000464341</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:65</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:1023-1031</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.eururo.2014.01.027</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-MAT</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.25</subfield><subfield code="j">Thermodynamik</subfield><subfield code="j">statistische Physik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">31.00</subfield><subfield code="j">Mathematik: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">65</subfield><subfield code="j">2014</subfield><subfield code="e">6</subfield><subfield code="h">1023-1031</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.3989916 |